Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Soule

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Endocrinology|May 15, 2009
Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?T J Cawood, P J Hunt, D O'Shea, et al.
Clinical Endocrinology|August 10, 2000
The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalismS Soule, C Van Zyl Smit, G Parolis, et al.
Journal of Clinical Pathology|August 27, 2002
HER-2/neu expression in germ cell tumoursS Soule, L Baldridge, K Kirkpatrick, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Endocrinology|May 15, 2009
Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?T J Cawood, P J Hunt, D O'Shea, et al.
Clinical Endocrinology|August 10, 2000
The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalismS Soule, C Van Zyl Smit, G Parolis, et al.
Journal of Clinical Pathology|August 27, 2002
HER-2/neu expression in germ cell tumoursS Soule, L Baldridge, K Kirkpatrick, et al.
Pageof 2